Patient Leaflet Updated 05-Aug-2025 | Ferring Pharmaceuticals Ltd
Pabal 100 micrograms in 1ml solution for injection
Pabal®
100 micrograms/ml solution for injection
Carbetocin
1. What Pabal is and what it is used for
2. What you need to know before you are given Pabal
3. How you are given Pabal
4. Possible side effects
5. How to store Pabal
6. Contents of the pack and other information
The active ingredient in Pabal is carbetocin. It is similar to a substance called oxytocin, which is naturally produced by the body to make the womb contract during childbirth.
Pabal is used to treat women who have just had a baby.
In some women, after delivery, the womb (uterus) doesn’t contract (shrink) quickly enough. This makes it more likely that they’ll bleed more than normal. Pabal makes the womb contract and so reduces the risk of bleeding.
Pabal must not be given until after the baby has been delivered.
Before giving you Pabal, your doctor needs to know about any medical conditions you may have. You should also tell your doctor about any new symptoms that develop while you are being treated with Pabal.
If any of these apply to you, tell your doctor, midwife or nurse.
Talk to your doctor, midwife or nurse before you are given Pabal
If any of these apply to you, tell your doctor, midwife or nurse.
Pabal may cause a build up of water in the body which can lead to drowsiness, listlessness and headache.
Not relevant in children below 12 years of age.
The experience with adolescents is limited.
Tell your doctor, midwife or nurse if you are taking, have recently taken or might take any other medicines.
Do not use Pabal during pregnancy and labour until after the baby has been delivered. Small amounts of carbetocin have been shown to pass from the nursings mother’s blood into the breast milk, but it is assumed to be degraded in the infant’s bowels. Breastfeeding does not need to be restricted after the use of Pabal.
Pabal is given as an injection into one of your veins or into one of your muscles, immediately after your baby has been delivered. The dose is one vial (100 micrograms).
If you are accidentally given too much Pabal, your womb may contract strongly enough to become damaged or to bleed heavily. You may also suffer drowsiness, listlessness and headache, caused by water building up in your body. You will be treated with other medication, and possibly surgery.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Not known: frequency cannot be estimated from the available data
Side effects seen with similar products that might be expected with carbetocin: irregular heartbeat, chest pain, fainting or palpitations which may mean the heart is not beating properly.
Infrequently some women might experience sweating.
Uncommon: may affect up to 1 in 100 people
Rare: may affect less than 1 in 1,000 people
Not known: frequency cannot be estimated from the available data
Side effects seen with similar products that might be expected with carbetocin: slow heartbeat, irregular heartbeat, chest pain, fainting or palpitations which may mean the heart is not beating properly.
If you get any side effects, talk to your doctor, midwife or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom:
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Ireland:
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and vial after EXP. The expiry date refers to the last day of that month.
Keep the vials in the outer carton in order to protect from light. Store below 30 ºC. Do not freeze.
The solution should be used immediately after opening of the vial.
The active substance is carbetocin. Each millilitre contains 100 micrograms of carbetocin.
The other ingredients are L-methionine, succinic acid, mannitol, sodium hydroxide and water for injections.
Pabal is clear colourless solution for injection, ready for intravenous or intramuscular injection, supplied in packs of five vials of 1 ml.
Pabal should be used only in well-equipped specialist obstetrics units.
UK marketing authorisation holder - PL 03194/0058
Irish product authorisation holder - PA 1009/21/1
This medicinal product is authorised in the Member States of the EEA under the following names: Pabal / DURATOCIN / DURATOBAL
This leaflet was last revised in June 2023.
Pabal, FERRING and the FERRING Logo are trademarks of Ferring B.V.
Drayton Hall, Church Road, West Drayton, UB7 7PS, UK
+44 (0)844 931 0051
http://www.ferring.co.uk
+44 (0)844 931 0050
0800 111 4125